XML 56 R43.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation - Stock Option Activity (Details)
6 Months Ended 12 Months Ended
Jul. 31, 2021
USD ($)
$ / shares
shares
Jan. 30, 2021
USD ($)
$ / shares
shares
Number of shares    
Options granted 1,518,154  
2016 Plan    
Number of shares    
Outstanding options at beginning of year 3,647,581  
Options granted 1,518,154 [1]  
Options exercised (7,270)  
Options expired and canceled (22,542)  
Outstanding options at end of quarter 5,135,923 3,647,581
Options exercisable at end of quarter 1,266,116  
2006 Plan    
Number of shares    
Outstanding options at end of quarter 412,826  
Weighted-average exercise price per option    
Outstanding options at beginning of year | $ / shares $ 1.09  
Options granted | $ / shares 0.71 [1]  
Options exercised | $ / shares 0.53  
Options expired and canceled | $ / shares 4.19  
Outstanding options at end of quarter | $ / shares 0.96 $ 1.09
Options exercisable at end of quarter | $ / shares $ 2.05  
Weighted-average remaining contractual term    
Outstanding options 8 years 6 months 8 years 6 months
Options exercisable at end of quarter 6 years 7 months 6 days  
Aggregate Intrinsic Value    
Outstanding options at beginning of year | $ $ 810,596  
Options exercised | $ 21,100  
Outstanding options at end of quarter | $ 20,488,700 $ 810,596
Options exercisable at end of quarter | $ $ 3,722,757  
[1] Primarily represents the grant of stock options to purchase an aggregate of 1,078,913 shares of the Company’s common stock, at an exercise price of $0.69 per share, in connection with the time-based grant of awards under its 2021-2023 LTIP, see Note 5, Long-Term Incentive Plans.  In March 2021, the Company also granted to active participants of the LTIP, a discretionary grant of stock options to purchase an aggregate of 414,337 shares of the Company’s common stock, at an exercise price of $0.75 per share, which will vest ratably over 3 years